Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Alamar Biosciences, Inc. (ALMR) had Return on Investments of -16.17% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
26.04M |
|
-21.32M |
|
11.58M |
|
14.46M |
|
38.38M |
|
-12.35M |
|
-8.51M |
|
-20.86M |
|
-20.86M |
|
-21.32M |
|
-21.32M |
|
-21.32M |
|
-21.32M |
|
-12.35M |
|
-11.11M |
|
12.26M |
|
12.26M |
|
-1.74 |
|
-1.74 |
|
| Balance Sheet Financials | |
141.47M |
|
10.47M |
|
44.98M |
|
186.45M |
|
24.05M |
|
74.97M |
|
105.48M |
|
129.53M |
|
-178.07M |
|
55.09M |
|
56.92M |
|
12.87M |
|
| Cash Flow Statement Financials | |
-20.35M |
|
-0.78M |
|
55.76M |
|
34.91M |
|
69.49M |
|
34.58M |
|
1.47M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.88 |
|
-- |
|
-- |
|
0.57 |
|
1.32 |
|
55.53% |
|
-47.42% |
|
-47.42% |
|
-- |
|
-80.13% |
|
-81.91% |
|
-20.95M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.29 |
|
1.33 |
|
67.49 |
|
11.98% |
|
-38.71% |
|
-11.44% |
|
|
Return on Investments |
-16.17% |
4.42 |
|
-1.71 |
|
-1.66 |
|